no abnormal phenotype detected_Fgfr2<tm2Schl>/Fgfr2<+>

http://metadb.riken.jp/0002169I129S1SvBALBcC57BL6Fgfr2tm2SchlFgfr2Fgfr2tm2SchlFgfr2

no abnormal phenotype detected_Fgfr2<tm2Schl>/Fgfr2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• fibroblast growth factor receptor 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:95523

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fgfr2<tm2Schl>/Fgfr2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fgfr2<tm2Schl>|Fgfr2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * BALB/c * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• no abnormal phenotype detected
  http://purl.obolibrary.org/obo/MP_0002169

文献

http://purl.org/net/cito/citesAsAuthority

• V P. Eswarakumar, et.al., Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis., Proceedings of the National Academy of Sciences of the United States of America, 2006, 103
  http://rdf.ncbi.nlm.nih.gov/pubmed/17132737